Latest immunotherapy news
Many Ineligible for Clinical Trial Could Benefit From Teclistamab for Multiple Myeloma
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Cell Therapy MDR-101 Produces Functional Immune Tolerance in Kidney Transplant Recipients
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
posted July 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer
posted June 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer 
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis 
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer .jpg)
Cancer Survivors Have Lower Levels of Physical Activity Related Articles
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
